Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 44 studies | 45% ± 18% | |
| endothelial cell | 40 studies | 46% ± 21% | |
| pericyte | 33 studies | 52% ± 22% | |
| endothelial cell of lymphatic vessel | 30 studies | 89% ± 11% | |
| smooth muscle cell | 21 studies | 33% ± 13% | |
| vein endothelial cell | 14 studies | 59% ± 16% | |
| connective tissue cell | 13 studies | 46% ± 10% | |
| endothelial cell of vascular tree | 13 studies | 34% ± 9% | |
| capillary endothelial cell | 12 studies | 39% ± 18% | |
| type II pneumocyte | 11 studies | 53% ± 15% | |
| endothelial cell of artery | 11 studies | 61% ± 28% | |
| myofibroblast cell | 10 studies | 32% ± 9% | |
| hepatocyte | 6 studies | 65% ± 26% | |
| epithelial cell | 6 studies | 29% ± 12% | |
| hematopoietic stem cell | 6 studies | 26% ± 6% | |
| ciliated cell | 6 studies | 22% ± 9% | |
| ionocyte | 5 studies | 27% ± 13% | |
| endothelial cell of sinusoid | 5 studies | 61% ± 29% | |
| adventitial cell | 5 studies | 61% ± 12% | |
| club cell | 5 studies | 19% ± 3% | |
| epithelial cell of proximal tubule | 4 studies | 22% ± 5% | |
| platelet | 4 studies | 22% ± 8% | |
| adipocyte | 4 studies | 44% ± 29% | |
| basal cell | 4 studies | 31% ± 10% | |
| hepatic stellate cell | 3 studies | 49% ± 23% | |
| glomerular endothelial cell | 3 studies | 32% ± 7% | |
| abnormal cell | 3 studies | 37% ± 19% | |
| extravillous trophoblast | 3 studies | 89% ± 7% | |
| endocardial cell | 3 studies | 62% ± 14% | |
| cholangiocyte | 3 studies | 64% ± 13% | |
| macrophage | 3 studies | 31% ± 15% | |
| pancreatic ductal cell | 3 studies | 39% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 9386.24 | 226 / 226 | 94% | 58.19 | 381 / 406 |
| lung | 100% | 14081.43 | 578 / 578 | 87% | 33.38 | 1002 / 1155 |
| kidney | 99% | 3851.97 | 88 / 89 | 86% | 52.53 | 773 / 901 |
| esophagus | 95% | 2961.10 | 1377 / 1445 | 64% | 11.99 | 118 / 183 |
| bladder | 100% | 3580.29 | 21 / 21 | 48% | 8.71 | 243 / 504 |
| pancreas | 55% | 888.70 | 182 / 328 | 90% | 24.08 | 160 / 178 |
| intestine | 98% | 2936.24 | 943 / 966 | 41% | 6.16 | 216 / 527 |
| breast | 100% | 5361.12 | 458 / 459 | 37% | 4.89 | 410 / 1118 |
| uterus | 99% | 2976.48 | 169 / 170 | 32% | 5.85 | 149 / 459 |
| stomach | 78% | 1688.72 | 279 / 359 | 51% | 7.77 | 147 / 286 |
| adrenal gland | 89% | 1370.05 | 230 / 258 | 24% | 3.84 | 55 / 230 |
| thymus | 99% | 4343.32 | 649 / 653 | 12% | 0.91 | 70 / 605 |
| prostate | 88% | 1947.54 | 216 / 245 | 19% | 2.89 | 95 / 502 |
| skin | 85% | 3560.49 | 1540 / 1809 | 19% | 2.90 | 92 / 472 |
| adipose | 100% | 6166.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4023.12 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 96% | 2177.27 | 172 / 180 | 3% | 0.37 | 13 / 430 |
| spleen | 96% | 2269.29 | 232 / 241 | 0% | 0 | 0 / 0 |
| heart | 96% | 2381.01 | 826 / 861 | 0% | 0 | 0 / 0 |
| muscle | 84% | 1713.99 | 673 / 803 | 0% | 0 | 0 / 0 |
| brain | 2% | 18.56 | 43 / 2642 | 39% | 5.53 | 275 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 31% | 4.86 | 14 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 1.33 | 5 / 29 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.50 | 3 / 80 |
| peripheral blood | 1% | 7.52 | 7 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030195 | Biological process | negative regulation of blood coagulation |
| GO_0071383 | Biological process | cellular response to steroid hormone stimulus |
| GO_0007596 | Biological process | blood coagulation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0009986 | Cellular component | cell surface |
| GO_0098552 | Cellular component | side of membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005901 | Cellular component | caveola |
| GO_0004866 | Molecular function | endopeptidase inhibitor activity |
| GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
| Gene name | TFPI |
| Protein name | Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI) Tissue factor pathway inhibitor |
| Synonyms | LACI TFPI1 |
| Description | FUNCTION: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma. |
| Accessions | ENST00000437725.5 ENST00000339091.8 [P10646-2] P10646 C9JT76 C9J103 C9JKV3 C9JP39 ENST00000409676.5 [P10646-2] ENST00000420747.1 ENST00000421427.5 ENST00000453013.5 C9JQ14 ENST00000435414.5 ENST00000392365.5 [P10646-1] ENST00000417013.5 ENST00000233156.9 [P10646-1] |